Quality of life and healthcare use in a randomized controlled lung cancer screening study

Annals of the American Thoracic Society

Volumn 10, Issue 4, 2013, Pages 324-329

  Mazzone, Peter J ^a   Obuchowski, Nancy ^b   Fu, Alex Z ^a   Phillips, Michael ^c   Meziane, Moulay ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Quantitative Health Sciences   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

Author keywords

Computer aided detection; EuroQol 5 Dimension; Lung nodules

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COMPUTER ASSISTED RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; SMOKING; THORAX RADIOGRAPHY;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOLITARY PULMONARY NODULE;

EID: 84883369729     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201301-007OC     Document Type: Article

References (22)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, FagerstromRM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National LungScreening Trial Research Team. Reduced lung-cancer mortalitywith low-dose computed tomographic screening. N Engl J Med2011;365: 395-409.
2. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, et al. Benefits and harms ofCT screening for lung cancer: a systematic review. JAMA 2012;307: 2418-2429.
3. Mazzone PJ, Obuchowski N, Phillips M, Risius B, Bazerbashi B, MezianeM. Lung cancer screening with computer aided detection chestradiography: design and results of a randomized, controlled trial. PLoSOne 2013;8: e59650.
4. Rabin R, de Charro F. EQ-5D: a measure of health status from theEuroQol Group. Ann Med 2001;33: 337-343.
5. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D healthstates: development and testing of the D1 valuation model. MedCare 2005;43: 203-220.
6. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation ofa new dyspnea measure: the UCSD Shortness of Breath Questionnaire.University of California, San Diego. Chest 1998;113: 619-624.
7. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-completemeasure of health status for chronic airflow limitation. The St.George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145: 1321-1327.
8. Kattan MW. Comparing treatment outcomes using utility assessmentfor health-related quality of life. Oncology (Williston Park) 2003;17: 1687-1693, discussion 1693-1694, 1697, 1701.
9. Ross PL, Littenberg B, Fearn P, Scardino PT, Karakiewicz PI, KattanMW. Paper standard gamble: a paper-based measure of standardgamble utility for current health. Int J Technol Assess Health Care2003;19: 135-147.
10. Medical expenditure panel survey [accessed 2012 May 9]. Availablefrom: http://meps.ahrq.gov/mepsweb/.
11. Silvestri GA, Nietert PJ, Zoller J, Carter C, Bradford D. Attitudestowards screening for lung cancer among smokers and their nonsmokingcounterparts. Thorax 2007;62: 126-130.
12. Dominioni L, Rotolo N, Poli A, Paolucci M, Sessa F, D'Ambrosio V, Paddeu A, Mantovani W, Imperatori A. Self-selection effects insmokers attending lung cancer screening: a 9. 5-year populationbasedcohort study in Varese, Italy. J Thorac Oncol 2010;5: 428-435.
13. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual AnalogScale. COPD 2005;2: 105-110.
14. Suzuki H, Sekine Y, Yoshida S, Suzuki M, Shibuya K, Takiguchi Y, Tatsumi K, Yoshino I. Efficacy of perioperative administration oflong-acting bronchodilator on postoperative pulmonary functionand quality of life in lung cancer patients with chronic obstructivepulmonary disease. Preliminary results of a randomized controlstudy. Surg Today 2010;40: 923-930.
15. van den Bergh KAM, Essink-Bot ML, Borsboom GJJM, Th Scholten E, Prokop M, de Koning HJ, van Klaveren RJ. Short-term healthrelatedquality of life consequences in a lung cancer CT screeningtrial (NELSON). Br J Cancer 2010;102: 27-34.
16. van den Bergh KAM, Essink-Bot ML, Bunge EM, Scholten ET, ProkopM, van Iersel CA, van Klaveren RJ, de Koning HJ. Impact ofcomputed tomography screening for lung cancer on participants ina randomized controlled trial (NELSON trial). Cancer 2008;113: 396-404.
17. Doyle S, Lloyd A, Walker M. Health state utility scores in advancednon-small cell lung cancer. Lung Cancer 2008;62: 374-380.
18. Grutters JPC, Joore MA, Wiegman EM, Langendijk JA, de RuysscherD, Hochstenbag M, Botterweck A, Lambin P, Pijls-Johannesma M.Health-related quality of life in patients surviving non-small celllung cancer. Thorax 2010;65: 903-907.
19. Lee LJH, Chung CW, Chang YY, Lee YC, Yang CH, Liou SH, Liu PH, Wang JD. Comparison of the quality of life between patients withnon-small-cell lung cancer and healthy controls. Qual Life Res 2011;20: 415-423.
20. Sturza J. A review and meta-analysis of utility values for lung cancer.Med Decis Making 2010;30: 685-693.
21. Ashraf H, Tønnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Døssing M. Effect of CT screening on smoking habits at 1-yearfollow-up in the Danish Lung Cancer Screening Trial (DLCST).Thorax 2009;64: 388-392.
22. Cox LS, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, Swensen SJ, Hurt RD. Change in smoking status after spiral chestcomputed tomography scan screening. Cancer 2003;98: 2495-2501.